• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:薛漓轩,周钱留,张媛媛,寇俊萍.中药活性成分防治脓毒症的研究进展[J].药学研究,2019,38(6):311-317,325[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2967次   下载 3379次 本文二维码信息
码上扫一扫!
中药活性成分防治脓毒症的研究进展
薛漓轩1,2,周钱留1,2,张媛媛1,2,寇俊萍1,2
字体:加大+|默认|缩小-
(1.中国药科大学中药学院中药药理与中医药系,江苏 南京 211198;2.江苏省中药评价与转换重点实验室,江苏 南京 211198)
摘要:
脓毒症(sepsis)是感染引起宿主反应失调所致的致命性器官功能障碍,其死亡率居高不下,严重威胁人类生命安全,治疗脓毒症的药物研究一直是全球研究的热点。近年来中药有效成分在治疗脓毒症方面取得许多进展,本文拟从抑制脓毒症期间的炎症反应、抑制氧化应激、调节免疫反应、调节细胞死亡、调节内皮屏障功能5个方面对近3年来发表在英文期刊上的中药活性成分防治脓毒症的机制进展予以综述,以期为研发防治脓毒症的新药提供参考依据和线索。
关键词:  中药  活性成分  脓毒症  多器官功能障碍  研究进展
DOI:10.13506/j.cnki.jpr.2019.06.001
基金项目:国家自然科学基金项目(No.81773971)
Advances of active components of traditional Chinese medicines in the prevention and treatment of sepsis
XUE Lixuan1,2,ZHOU Qianliu1,2,ZHANG Yuanyuan1,2,KOU Junping1,2
(1.Department of Pharmacology of Chinese Material Medical, School of Traditional Chinese Pharmacy,China Pharmaceutical University,Nanjing 211198,China;2.Jiangsu Key Laboratory of Traditional Chinese Medicine Evaluation and Translational Research,Nanjing 211198,China)
Abstract:
Sepsis is a common critical disease in intensive care unit, also a dysregulated systemic inflammatory and immune response to microbial invasion that produces organ injury. Sepsis has a high mortality rate, which is a serious threat to human life. It’s a hot topic on development of new drug to treat sepsis in global. Many advances of active components from traditional Chinese medicines (TCMs) were reported in the treatment of sepsis in recent years. This article reviews the research progress of TCMs in the prevention and treatment of sepsis reported by foreign journals in the past three years, which includes five aspects such as inhibition of inflammatory reaction, inhibition of oxidative stress, regulation of immune response, regulation of cell death and endothelial barrier function etc, with an attempt to provide the theoretical basis for the development of new drugs for sepsis.
Key words:  Traditional Chinese medicines  Active components  Sepsis  Multiple organ dysfunction  Research progress
今日访问量:2493    总访问量:55338936
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司